The fragile X [fra(X)] syndrome is the most common form of inherited mental retardation and one of the most prevalent of all known genetic diseases. One of the many intriguing aspects of this syndrome is the significant degree of phenotypic heterogeneity with which it is associated. The wide spectrum of cognitive and behavioral functioning is particularly impressive; however, the basis for this variability has not yet been identified. Recently, the fra(X) syndrome has been found to be the result of an increased number of CGG triplet repeats found in the 5' untranscribed region of the fra(X) mental retardation-1 gene (FMR-1). Studies of fra(X) families have shown that this region is unstable during meiosis; however, factors affecting this instability are unknown. The purpose of this project is to examine the characteristics of the FMR-1 gene in a school-aged, special needs population in order to test three specific hypotheses involving the prevalence of the fra(X) mutation, the correlation between the FMR-1 genotype and phenotype, and the mutation rates that lead to the clinically expressed syndrome. The targeted study population make this study unique. First, children with special educational needs are at higher risk for carrying the fra(X) mutation than the general population; however, they are not a clinically-referred population. Thus, we can expect adequate sample sizes on which to base genotype-phenotype analyses and also be assured that the phenotype will not be biased towards features of the fra(X) syndrome. Secondly, direct assessment of identified subjects and family members is possible since this is not an anonymous sample. The data gathered from these studies are important from a research, clinical and public health standpoint. The results from the correlation between genotype and phenotype will provide information about the normal functioning of the FMR-1 gene and may shed light on biological factors which underlie other disorders that involve cognitive and behavioral capacity. The characterization of the transmission of the FMR-1 gene in a non-clinically referred population will provide hypotheses concerning the underlying biological mechanisms of instability. As other genes are now found to contain similar repeat regions, the knowledge gained from this study will have a wide application to other disorders. Lastly, evaluation of the prevalence of fra(X) mutation carriers and the range of expression are the first steps that are needed before assessing the feasibility of mass screening for the fra(X) syndrome.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD029909-04
Application #
2403290
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1994-05-05
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Nolin, Sarah L; Sah, Sachin; Glicksman, Anne et al. (2013) Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A:771-8
Visootsak, Jeannie; Charen, Krista; Rohr, Julia et al. (2012) Diagnosis of fragile X syndrome: a qualitative study of African American families. J Genet Couns 21:845-53
Hunter, Jessica Ezzell; Sherman, Stephanie; Grigsby, Jim et al. (2012) Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology 26:156-64
Hunter, Jessica Ezzell; Leslie, Mary; Novak, Gloria et al. (2012) Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet 159B:549-59
Juncos, Jorge L; Lazarus, Joash T; Rohr, Julia et al. (2012) Olfactory dysfunction in fragile X tremor ataxia syndrome. Mov Disord 27:1556-9
Hunter, Jessica Ezzell; Epstein, Michael P; Tinker, Stuart W et al. (2012) The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet 42:415-22
Spath, Marian A; Feuth, Ton B; Smits, Arie P T et al. (2011) Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13:643-50
Chang, Martin C; DeCaro, John J; Zheng, Mei et al. (2011) Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology 59:1018-23
Allen, Emily Graves; Hunter, Jessica E; Rusin, Michele et al. (2011) Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology 25:404-411
Spath, M A; Feuth, T B; Allen, E G et al. (2011) Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod 26:2185-91

Showing the most recent 10 out of 41 publications